FR2487201B2 - Preparation lymphocytaires applicables en therapeutique humaine, procede d'obtention et applications - Google Patents

Preparation lymphocytaires applicables en therapeutique humaine, procede d'obtention et applications

Info

Publication number
FR2487201B2
FR2487201B2 FR8113524A FR8113524A FR2487201B2 FR 2487201 B2 FR2487201 B2 FR 2487201B2 FR 8113524 A FR8113524 A FR 8113524A FR 8113524 A FR8113524 A FR 8113524A FR 2487201 B2 FR2487201 B2 FR 2487201B2
Authority
FR
France
Prior art keywords
lymphocytaic
obtaining
applications
human therapeutics
preparation applicable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8113524A
Other languages
English (en)
Other versions
FR2487201A2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8006537A external-priority patent/FR2478470A1/fr
Priority claimed from CH542980A external-priority patent/CH650932A5/fr
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Publication of FR2487201A2 publication Critical patent/FR2487201A2/fr
Application granted granted Critical
Publication of FR2487201B2 publication Critical patent/FR2487201B2/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6006—Cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR8113524A 1980-03-24 1981-07-09 Preparation lymphocytaires applicables en therapeutique humaine, procede d'obtention et applications Expired FR2487201B2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8006537A FR2478470A1 (fr) 1980-03-24 1980-03-24 Preparations cellulaires applicables en therapeutique humaine, procede d'obtention et applications
CH542980A CH650932A5 (en) 1980-07-15 1980-07-15 Cell preparations which can be used in human therapy and method for obtaining them

Publications (2)

Publication Number Publication Date
FR2487201A2 FR2487201A2 (fr) 1982-01-29
FR2487201B2 true FR2487201B2 (fr) 1985-07-05

Family

ID=25697672

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8113524A Expired FR2487201B2 (fr) 1980-03-24 1981-07-09 Preparation lymphocytaires applicables en therapeutique humaine, procede d'obtention et applications

Country Status (1)

Country Link
FR (1) FR2487201B2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59151885A (ja) * 1983-02-18 1984-08-30 Eisai Co Ltd 成人ｔ細胞白血病関連細胞株
FR2578745B1 (fr) * 1985-03-18 1989-05-12 Berdal Pascal Preparations pharmaceutiques fluidifiant le sang
FR2587217B1 (fr) * 1985-03-18 1991-10-18 Berdal Pascal Preparations pharmaceutiques immunomodulantes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1945251A1 (de) * 1969-09-06 1971-03-11 Karl Dr Med Theurer Verfahren zur Beeinflussung der quantitativen Antikoerperbildung bei der aktiven Immunisierung und der Desensibilisierung
US4144131A (en) * 1974-05-23 1979-03-13 Wisconsin Alumni Research Foundation Immobilization of enzymes on human tissue or erythrocytes
DE2860875D1 (en) * 1977-09-28 1981-10-15 Nat Res Dev Immunological preparations incorporating mhc antigens and their production

Also Published As

Publication number Publication date
FR2487201A2 (fr) 1982-01-29

Similar Documents

Publication Publication Date Title
FR2593809B1 (fr) Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
BE892758A (fr) Derives phenylcyclobutyliques, leur procede de preparation et leur application therapeutique
FR2504920B1 (fr) Derives phenylcyclobutyliques, leur procede de preparation et leur application therapeutique
FR2509310B1 (fr) Nouvelles cephalosporines, leur procede de preparation et leur application en therapeutique
BE866807A (fr) Nouvelle glycoproteine, son procede d'obtention et son application therapeutique
MC1499A1 (fr) Interferon immun humain homogene et procede pour sa preparation
FR2348907A1 (fr) Derives polyprenyliques,leur procede de preparation et leur application en therapeutique
MA19331A1 (fr) Derives de la thieno - pyridinone , leur procede de preparation et leur application therapeutique .
BE888578A (fr) Composition de sec-butylbiphenyle et procede d'obtention,
BE854133A (fr) 1,3-dihydro-heteroarylspito(isobenzofurannes)et leur procede de preparation et leur application therapeutique
BE863089A (fr) Inhibiteur d'alpha-amylase, son procede de preparation a partir d'un streptomycete et son application en therapeutique
FR2487201B2 (fr) Preparation lymphocytaires applicables en therapeutique humaine, procede d'obtention et applications
BE884602R (fr) Nouvelles cinnamoyles piperazines et homopiperazines leur procede de preparation et leur application en therapeutique
FR2352825A1 (fr) 3,5,5-trimethylhexanoyl-ferrocene son procede de preparation et ses applications en therapeutique
BE895445A (fr) Dihydro- et tetrahydromonacolines l, leur procede de preparation et leur application en tjerapeutique
BE895213A (fr) Derives d'azolyl-pentene, leur procede de preparation et leur utilisation
BE863402A (fr) Azacycloalcanes, azacycloalcenes et derives de ceux-ci, leur procede de preparation et leur application en therapeutique
FR2351098A1 (fr) Derives de l'isothiouree, leur procede de preparation et leur application therapeutique
BE862878A (fr) Alkylthio-7,8-dihydroxy-1-phenyl-2,3,4,5,-tetrahydro-1h-3-benzazepines, leurs procede de preparation et application en therapeutique
FR2542744B2 (fr) 3',5'-diarabinosides, leur preparation et leur application en therapeutique
FR2343746A1 (fr) Nouvelles cephalosporines, leur procede de preparation et leur application en therapeutique
BE864111A (fr) Pyrazolo-oxazepines et pyrazolo-thiazepines, leur procede de preparation et leurs applications en therapeutique
FR2527630B1 (fr) Enzyme leucocytaire humaine de type pepsique, procede pour sa preparation et agent therapeutique la contenant
FR2690917B1 (fr) Aminoesters, leur procede de preparation et leur application en therapeutique.
BE891468A (fr) Derives d'imidazole, leur procede de preparation et leur application therapeutique

Legal Events

Date Code Title Description
TP Transmission of property
CL Concession to grant licenses